Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...

Dan’s emergency came just as UH St. John completed the renovation of its cardiac catheterization lab, equipped with state-of-the-art technology for cardiac and peripheral vascular procedures. On that ...

HOUSTON, TN — The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus statement for managing patients with cancer who are seen in the cardiac ...

Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...